A Glomus Jugulare Tumor is a type of tumor that grows in a specific part of the inner ear near the jugular vein. It can cause symptoms like dizziness, hearing loss, and paralysis of the vocal cords. It's usually treated with radiation therapy.
Every report comes from a Lived member, sent anonymously.
Have you had Radiosurgery for Glomus Jugulare Tumor?
A glomus jugulare tumor is a rare, usually slow-growing tumor at the base of the skull, just below the middle ear, where the jugular vein (the large vein that drains blood from the brain) leaves the skull. Doctors now usually call it a jugular paraganglioma. It grows from paraganglia, small clusters of nerve-related cells that sit along blood vessels and nerves, and it is usually not cancer. The tumor causes trouble mainly because of where it sits. It has a rich blood supply and lies beside the structures of hearing and several nerves that control swallowing, the voice, the shoulder and the tongue. The most common first symptom is pulsatile tinnitus, a rhythmic whooshing in one ear that keeps time with the heartbeat. Many people also have some hearing loss or a feeling of fullness in that ear. As the tumor presses on nearby nerves, hoarseness or trouble swallowing can develop, and less often weakness of the face or tongue. A related tumor that stays within the middle ear is called a glomus tympanicum, and doctors often group the two as jugulotympanic paragangliomas.
Most glomus jugulare tumors have no known trigger, and nothing a person did causes one. Inheritance plays a larger part than in most tumors, though. Up to about 4 in 10 head and neck paragangliomas are linked to an inherited change in a gene, most often one of the SDH genes (succinate dehydrogenase genes, which run part of a cell's energy machinery and normally help keep tumors from forming). The best-known inherited form, familial paraganglioma type 1, comes from changes in the SDHD gene. It usually causes tumors only when the gene change is passed down from the father, which is one reason it can skip generations and seem to come from nowhere. Many people with an inherited gene change have no known affected relatives, so the absence of a family history does not rule it out. Tumors that appear at a younger age, or more than one tumor, point more strongly toward a genetic cause. Jugular tumors are diagnosed most often in middle age and are more common in women.
A doctor may first suspect this tumor on looking in the ear and seeing a reddish-purple mass behind the eardrum, or when a scan done for hearing loss or tinnitus shows it. A hearing test measures how much hearing is affected, and an examination checks the nerves to the face, throat, shoulder and tongue, since weakness there changes the treatment discussion. Imaging confirms the diagnosis and maps the tumor. MRI (magnetic resonance imaging), often with a CT (computed tomography) scan, shows its size and how it relates to the surrounding bone, blood vessels and nerves. A specialized PET (positron emission tomography) scan that uses a tracer called gallium-68 DOTATATE, which paraganglioma cells take up, can find small additional tumors elsewhere in the body. Blood or urine tests for metanephrines (breakdown products of stress hormones) check whether the tumor releases noradrenaline, a hormone that raises blood pressure and heart rate. Only about 1 in 20 head and neck paragangliomas does, and a normal result does not rule the tumor out, but finding one matters because it needs preparation with blood pressure medicine before any procedure. Because these tumors are so often inherited, genetic testing is recommended for everyone diagnosed, whether or not anyone else in the family is known to be affected.
Because most of these tumors grow very slowly and rarely threaten life on their own, treatment aims first to protect hearing, voice and swallowing rather than to remove the tumor at any cost. The choice is best made with an experienced skull base team that brings together ear and skull base surgeons, radiation specialists, endocrinologists and genetics specialists. Watching with regular scans (active surveillance) is a common first choice, especially for older people and those with few symptoms. Many jugular tumors grow less than a millimeter a year, and some don't grow at all. The trade-off is that nerve problems can still appear or worsen during this time, so the exams and scans are what tell the team when to act. Radiation is the usual choice when a tumor is growing or causing new problems. It can be given as stereotactic radiosurgery, a precisely focused dose usually delivered in a single session (Gamma Knife is one well-known system), or as conventional radiation over several weeks. Either approach stops growth in roughly 95 out of 100 treated tumors. The tumor usually shrinks only a little, and hearing that has already been lost seldom returns, although tinnitus improves for about half of people. Short-term side effects such as a dry mouth or nausea are usually mild, and new nerve damage is uncommon. The longer-term concern, a small risk of a radiation-related tumor or stroke years later, weighs more heavily for younger people. Surgery is the standard choice for a small tumor confined to the middle ear, which can usually be removed with little lasting harm. For larger tumors around the jugular vein, surgery more often leaves new weakness in swallowing, the voice or the face, so surgeons frequently remove only the part that can safely come out. Surgery is generally favored when the nerves are already affected, when radiation has not controlled the tumor, when the tumor releases hormones, or for some inherited gene types (such as SDHB) that carry a higher risk of spread.
For most people, a glomus jugulare tumor is a long-term condition to manage rather than a threat to life. Deaths from tumors that have not spread are almost unheard of, and only a few percent of jugular tumors ever spread to lymph nodes or elsewhere in the body. Day to day, the main effects are on hearing, the voice and swallowing. Some people live for years with little more than tinnitus. Others adjust to hearing loss in one ear, or to a weak vocal cord and swallowing changes from nerve involvement or surgery. Voice and swallowing therapy can help, and procedures that reposition a weak vocal cord can improve the voice. Some of these changes are permanent, which is why the risks of treatment are weighed so carefully against a tumor's slow pace. Follow-up lasts many years. During surveillance, a repeat MRI is often done about six months after diagnosis and then roughly once a year, along with hearing and nerve checks. After treatment, scans continue for years because a tumor can regrow late, sometimes more than five years afterward. People with an inherited gene change usually need regular hormone tests and imaging from the skull base to the pelvis to look for tumors elsewhere, and their relatives may be offered genetic testing and, if they carry the change, screening that starts in late childhood.
Arrange a medical evaluation if you hear a persistent whooshing or pulsing sound in one ear, or have hearing loss or fullness in one ear that does not clear. Hoarseness that lasts more than three weeks also deserves evaluation. If a relative has been found to carry a hereditary paraganglioma gene change, ask about genetic counseling even if you have no symptoms. If you already have this tumor, contact your care team soon, without waiting for the next scheduled scan, if new problems appear: hoarseness, coughing or choking when you drink or swallow, weakness on one side of the face, shoulder or tongue, or a clear drop in hearing. These can mean the tumor is affecting nerves and may change the plan. Also report spells of pounding heartbeat, sweating and headache, or blood pressure that has become high or hard to control, since these can mean a tumor is releasing hormones.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Glomus Jugulare Tumor is like, what's helped you, or ask the community a question.